Treat-and-extend regimens with anti-vascular endothelial growth factor agents in age-related macular degeneration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treat-and-extend regimens with anti-vascular endothelial growth factor agents in age-related macular degeneration

Published:2019-11-02 Issue:6 Volume:14 Page:287-307
ISSN:1746-9899
Container-title:Expert Review of Ophthalmology
language:en
Short-container-title:Expert Review of Ophthalmology

Author:

Yu Siqing¹,Rückert René²,Munk Marion R.¹³

Affiliation:

1. Department of Ophthalmology and Department of Clinical Research, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

2. Eyegnos consulting, Bern, Switzerland

3. Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

Publisher

Informa UK Limited

Subject

Optometry,Ophthalmology,Biomedical Engineering

Link

https://www.tandfonline.com/doi/pdf/10.1080/17469899.2019.1698948

Reference130 articles.

1. The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration

2. Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases

3. Incidence of Legal Blindness From Age-Related Macular Degeneration in Denmark: Year 2000 to 2010

4. Reducing the clinical burden of ranibizumab treatment for neovascular age-related macular degeneration using an individually planned regimen

5. Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of an Artificial Intelligence-Based Detector of Sub- and Intraretinal Fluid on a Large Set of Optical Coherence Tomography Volumes in Age-Related Macular Degeneration and Diabetic Macular Edema;Ophthalmologica;2022

2. Machine learning can predict anti-VEGF treatment demand in a Treat-and-Extend regimen for patients with nAMD, DME and RVO associated ME;Ophthalmology Retina;2021-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3